365 related articles for article (PubMed ID: 30036516)
1. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
Doizi S; Poindexter JR; Pearle MS; Blanco F; Moe OW; Sakhaee K; Maalouf NM
J Urol; 2018 Dec; 200(6):1278-1284. PubMed ID: 30036516
[TBL] [Abstract][Full Text] [Related]
2. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
3. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
4. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
[TBL] [Abstract][Full Text] [Related]
5. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
6. Differences in 24-hour urine composition between apatite and brushite stone formers.
Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
Urology; 2013 Oct; 82(4):768-72. PubMed ID: 23791217
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
[TBL] [Abstract][Full Text] [Related]
8. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
[TBL] [Abstract][Full Text] [Related]
9. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
Berg C; Larsson L; Tiselius HG
J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
[TBL] [Abstract][Full Text] [Related]
10. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
11. The most important metabolic risk factors in recurrent urinary stone formers.
Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
Sakhaee K; Nicar M; Hill K; Pak CY
Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
[TBL] [Abstract][Full Text] [Related]
13. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.
Fuselier HA; Moore K; Lindberg J; Husserl FE; Cole FE; Kok DJ; Whitehead D; Galliano DJ; Erwin DT
Urology; 1998 Dec; 52(6):988-94. PubMed ID: 9836542
[TBL] [Abstract][Full Text] [Related]
14. Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.
Trinchieri A; Lizzano R; Marchesotti F; Zanetti G
Urol Res; 2006 Feb; 34(1):1-7. PubMed ID: 16425021
[TBL] [Abstract][Full Text] [Related]
15. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
[TBL] [Abstract][Full Text] [Related]
16. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
17. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
[TBL] [Abstract][Full Text] [Related]
18. Chronopharmacological studies on potassium citrate treatment of oxalocalcic urolithiasis.
Grases F; Conte A; March JG; GarcĂa-Ferragut L; Villalonga N
Int Urol Nephrol; 1997; 29(3):263-73. PubMed ID: 9285296
[TBL] [Abstract][Full Text] [Related]
19. Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.
Krieger NS; Asplin JR; Granja I; Ramos FM; Flotteron C; Chen L; Wu TT; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2019 Jul; 30(7):1163-1173. PubMed ID: 31101664
[TBL] [Abstract][Full Text] [Related]
20. Calcium-to-Citrate Ratio Distinguishes Solitary and Recurrent Urinary Stone Forming Children.
DeFoor W; Jackson E; Schulte M; Alam Z; Asplin J
J Urol; 2017 Aug; 198(2):416-421. PubMed ID: 28365270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]